CD274 and prostate carcinoma: To the best of our knowledge, this study is the first to show that AREG promotes upregulation of intratumoral PD-L1 levels in HGSOC, as there been only one study in prostate cancer that previously demonstrated that paracrine AREG induces PD-L1 activity (Xu et al., 2019).